Too many diagnoses, or too many decades without one? – Crystal Pathways Panel Debate

Free Panel Debate · 2 July 2026

Too many diagnoses, or too many decades without one?

Neurodevelopmental Assessment. The clinical evidence, the commissioning pressure, and the people caught in between.

Thursday 2 July 2026

2:00pm – 2:45pm BST · Online

Free to attend
View details

About this debate

Earlier this year, the Government commissioned a review into ADHD and autism. The review concluded that both conditions are under-recognised, under-diagnosed and under-treated in England. The headlines that followed reported over-diagnosis. This panel is about what the evidence actually shows, and what needs to change before more people spend decades waiting to be seen.

On 2 July, Crystal Pathways is bringing together clinicians, a former NHS commissioner, a GP, and someone who lived the question personally, for an honest, unscripted conversation about what the current narrative gets wrong.

The panel

Dr Filip Singh

Dr Filip Singh (Chair)

Managing Director, Crystal Pathways. Doctorate in Clinical Psychology. ADHD.

The clinical and strategic case, and why the current narrative is not grounded in evidence.

Dr Nick Dattani

Dr Nick Dattani

General Practitioner

What shared care for ADHD and autism actually looks like from primary care, and where the system breaks down.

Dr Swanand Patwardhan

Dr Swanand Patwardhan

Consultant Psychiatrist, Crystal Pathways

What good ADHD and autism assessment looks like, and whether the quality problem is being misread as a volume problem.

Cat Pritchard

Cat Pritchard

Former NHS Commissioner. Head of Health Integration, Crystal Pathways.

What commissioning decisions actually look like from inside the room, and what would need to change.

Dr Denika Campbell-Lee

Dr Denika Campbell-Lee

Clinical Psychologist, Crystal Pathways

The bio-psycho-social model and the international evidence: is the UK an outlier, and what does under-diagnosis cost the system?

Sophia Marks

Sophia Marks

Diagnosed with ADHD at 39.

Brings lived expertise on what late diagnosis actually costs and why it happens.

What this session covers

  • Where the clinical evidence on diagnostic rates actually sits
  • Whether rising referrals signal a problem or a backlog
  • The gender and equity dimensions of late diagnosis
  • What the downstream cost of under-diagnosis looks like
  • What commissioners, GPs, and referrers can do differently

Reserve your place

Free to attend · 45 minutes

No sales pitch. Just clinical substance.

“We look at the whole person – physical health, psychological history, social circumstances – together.”